Send me a link:

*Text messaging rates may apply.

 Dow Down0.11% Nasdaq Up0.44%

More On P31.SI

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Pharmesis International Ltd. (P31.SI)

-SES
0.04 0.00(0.00%) Jul 22
ProfileGet Profile for:
Pharmesis International Ltd.
No. 8 Yingbin Road
Chengdu,
China - Map
Website: http://www.pharmesis.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Major
Full Time Employees:N/A

Business Summary 

Pharmesis International Ltd., an investment holding company, develops, manufactures, and sells western medicines, health tonic products, and traditional Chinese medicine (TCM) formulated products in the People’s Republic of China. The company operates through Western Drugs, TCM Formulated Drugs, and Distribution segments. It is also involved in the wholesale of chemical drugs, biological raw products, TCMs, antibiotics, and antibiotics agents. The company offers its western medicines and TCM formulated products in the form of tablets, granules, pills, etc. Its products comprise Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Xiao Shi Jian Pi tablets for the treatment of flatus, inappetency, dyspepsy, and spleen weakness; and LianPu ShuangQing for the treatment of acute inflammation, such as dysentery and intestinal infection. Pharmesis International Ltd. also offers Shulinghou tablets, which clear heat and regenerate body fluid, as well as for the treatment of acute and chronic pharyngitis, laryngitis, sore throat, and hoarseness; Er Ding granules for the treatment of jaundice, as well as clears heat toxics; and AFenKa for the treatment of migrane, pain, headache, cold, nasosinusitis, muscle pain, menstrual pain, toothache, and arthritis. In addition, the company provides Wuling Jiao Nang granules, which disperse water accumulation, regulate water circulation, and dispel dampness; Bear Bile and Bulbus Fritillariae oral liquid for the treatment of phlegmheat cough; and Gansu for the treatment of acute and chronic hepatitis. Pharmesis International Ltd. markets its western drugs under the Kinna brand name; and TCM formulated drugs under the Longlife brand name to approximately 2,000 hospitals through its sales and marketing personnel. The company was founded in 1996 and is headquartered in Chengdu, the People’s Republic of China.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Pharmesis International Ltd.

Key Executives 
 PayExercised
Mr. Xuedan Wu , 51
Chief Exec. Officer, Exec. Director and Member of Nominating Committee
N/AN/A
Ms. Siaw Yean Tee , 38
Financial Controller
N/AN/A
Dr. Deng Zemin ,
Head of Research
N/AN/A
Ms. Siew Tian Low ACIS,
Joint Company Sec.
N/AN/A
Ms. Lai Yin Chan ,
Joint Company Sec.
N/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in SGD.